ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,212.20
0.10%
S&P ASX All Technology
3,444.90
0.35%
Brent Oil
70.57
-0.54%
US Dollar vs AUD
1.4445
-0.44%
Bitcoin
65,443.68
0.40%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Cerevel Therapeutics Holdings Inc (CERE)

  7. Cerevel Therapeutics Holdings Inc (CERE) News

CERE

Cerevel Therapeutics (CERE)

Cerevel Therapeutics Holdings Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CERE
DateTimeSourceHeadlineSymbolCompany
12/08/202421:30Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:CERECerevel Therapeutics Holdings Inc
06/08/202414:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CERECerevel Therapeutics Holdings Inc
06/08/202414:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CERECerevel Therapeutics Holdings Inc
06/08/202414:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CERECerevel Therapeutics Holdings Inc
06/08/202406:38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CERECerevel Therapeutics Holdings Inc
06/08/202406:34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CERECerevel Therapeutics Holdings Inc
06/08/202406:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CERECerevel Therapeutics Holdings Inc
06/08/202406:30Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:CERECerevel Therapeutics Holdings Inc
06/08/202406:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CERECerevel Therapeutics Holdings Inc
06/08/202406:26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CERECerevel Therapeutics Holdings Inc
06/08/202406:24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CERECerevel Therapeutics Holdings Inc
01/08/202423:33Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:CERECerevel Therapeutics Holdings Inc
01/08/202423:32Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:CERECerevel Therapeutics Holdings Inc
01/08/202423:27Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:CERECerevel Therapeutics Holdings Inc
01/08/202423:26Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:CERECerevel Therapeutics Holdings Inc
01/08/202423:25Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:CERECerevel Therapeutics Holdings Inc
01/08/202423:24Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:CERECerevel Therapeutics Holdings Inc
01/08/202422:36Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CERECerevel Therapeutics Holdings Inc
01/08/202422:23PR Newswire (US)AbbVie Completes Acquisition of Cerevel TherapeuticsNASDAQ:CERECerevel Therapeutics Holdings Inc
09/05/202406:17Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CERECerevel Therapeutics Holdings Inc
18/04/202420:30GlobeNewswire Inc.Cerevel Therapeutics Announces Positive Topline Results for Tavapadon in Phase 3 Adjunctive Trial for People Living with Parkinson’s DiseaseNASDAQ:CERECerevel Therapeutics Holdings Inc
28/02/202408:02Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:CERECerevel Therapeutics Holdings Inc
17/02/202408:46Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CERECerevel Therapeutics Holdings Inc
10/02/202401:00Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:CERECerevel Therapeutics Holdings Inc
09/02/202411:19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CERECerevel Therapeutics Holdings Inc
25/01/202400:30PR Newswire (US)Kuehn Law Encourages MDC, WAVD, NS and CERE Investors to Contact Law FirmNASDAQ:CERECerevel Therapeutics Holdings Inc
24/01/202409:51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CERECerevel Therapeutics Holdings Inc
24/01/202409:50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CERECerevel Therapeutics Holdings Inc
24/01/202409:46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CERECerevel Therapeutics Holdings Inc
24/01/202409:37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CERECerevel Therapeutics Holdings Inc
 Showing the most relevant articles for your search:NASDAQ:CERE

Your Recent History

AMEX
KCCA
KraneShares California C...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved